Phreesia, Inc. (NYSE:PHR) Given Consensus Rating of “Buy” by Analysts

Shares of Phreesia, Inc. (NYSE:PHR) have been assigned a consensus recommendation of “Buy” from the thirteen analysts that are presently covering the stock, Marketbeat Ratings reports. Thirteen analysts have rated the stock with a buy rating. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $31.15.

A number of analysts have commented on the company. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and boosted their price objective for the stock from $24.00 to $32.00 in a report on Wednesday, January 8th. JMP Securities reiterated a “market outperform” rating and set a $30.00 price target on shares of Phreesia in a report on Tuesday, December 10th. Robert W. Baird lowered their price target on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, December 11th. Citigroup lifted their price objective on shares of Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, January 10th. Finally, KeyCorp upped their target price on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 8th.

Insider Activity

In other Phreesia news, CFO Balaji Gandhi sold 28,759 shares of the company’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $30.00, for a total transaction of $862,770.00. Following the sale, the chief financial officer now directly owns 116,174 shares of the company’s stock, valued at $3,485,220. This represents a 19.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Evan Roberts sold 3,519 shares of the stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $30.06, for a total transaction of $105,781.14. Following the transaction, the chief operating officer now owns 741,197 shares of the company’s stock, valued at $22,280,381.82. This represents a 0.47 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 195,740 shares of company stock valued at $5,441,409 in the last three months. Company insiders own 5.80% of the company’s stock.

Institutional Trading of Phreesia

A number of institutional investors have recently modified their holdings of the business. Johnson Financial Group Inc. raised its holdings in Phreesia by 381.3% during the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock valued at $28,000 after acquiring an additional 896 shares during the period. R Squared Ltd purchased a new position in shares of Phreesia in the fourth quarter valued at $30,000. International Assets Investment Management LLC raised its stake in shares of Phreesia by 2,179.7% during the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after purchasing an additional 1,395 shares during the period. BankPlus Trust Department purchased a new stake in Phreesia during the 4th quarter worth about $34,000. Finally, Quarry LP boosted its stake in Phreesia by 210.9% in the 4th quarter. Quarry LP now owns 2,835 shares of the company’s stock worth $71,000 after purchasing an additional 1,923 shares during the period. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Phreesia Stock Down 5.8 %

Shares of NYSE:PHR opened at $24.27 on Friday. The firm has a market cap of $1.41 billion, a P/E ratio of -16.51 and a beta of 1.03. Phreesia has a 52-week low of $17.07 and a 52-week high of $30.53. The business’s 50 day simple moving average is $27.50 and its two-hundred day simple moving average is $24.04. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. During the same quarter last year, the firm posted ($0.58) EPS. Phreesia’s revenue was up 16.6% compared to the same quarter last year. As a group, research analysts forecast that Phreesia will post -1.1 EPS for the current fiscal year.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.